Group items tagged

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

[300 Pages Report] European Drug Delivery Technologies Market report categorizes the European Market by Technologies (Auto Injectors, Transdermal Patches , Injectable, Ocular, Transdermal , Oral, Pulmonary, Nasal, Topical, Implantable, and Transmucosal Drug Delivery) & by Geography

North American Drug Delivery Technology Market categories the global market by technology (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) & by Geography

The report extensively covers the healthcare provider IT and payer IT markets. The market in this report has been segmented on the basis of its applications, delivery modes, and components. Based on applications, the healthcare information technology is segmented into provider (clinical information technology and non-clinical information technology) and payer, while the market by delivery mode is further categorized as on-premises, web-based, and cloud-based.

Drug Delivery Technology Market Report categorizes the Global Market by Metered Dose Inhalers, Auto Injectors, Transdermal Patches, Drug Eluting Stentscand Infusion Pumps Forecasting - 2017

[Price: $4650] [No of slides - 130] Browse 9 tables and 26 figures/charts on Transfection Market analysis & categorizes (Gene, DNA, Protein, SiRNA, Cell Transfection) the market size and global revenue has been forecasted based on four segmentation: technology, products, applications and by geography.

European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017

The "Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017", analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.

Vaccine Market categories the Global Market by Technology Trend Analysis By Various Classes - Live/Attenuated, Toxoid, Subunit, Conjugate, Recombinant Vector, DNA, Synthetic, Dentritic Vaccines And By Indications -Cancer, Allergy, Diabetes, Infectious Diseases, Cardiovascular Disease by Geography

Ablation Devices Market to 2016 - (Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Cardiac, Cancer and Gynecology) - Global Market Forecast and Trends Analysis by Technology, Devices & Applications

Endoscopy market research report provides comprehensive analysis on global market of endoscopy by products/devices, applications and technology.

Advances in Magnetic Resonance Imaging (MRI) System Market (2013-2018) - Technology Trend Analysis - By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis - Estimates up to 2018

[171 Slides Report] Aptamers Market categories the global market By Applications - Biosensors , Biomarker Discovery , Therapeutics , Diagnostics, Drug Discovery, by Technology Trends & by Geography

A humble start by M. K. Narasinga Rao and Chitra krishnan into health care sector, Magal health care was formed in 2009, dealing products with international quality compliance ensuring not only complete credibility of the products but also credible services to the customers and in turn their customers. Based on extensive long term experience of distribution and experience in sales and marketing of medical devices & medical consumables within the sub-continent region, and with a comprehensive understanding of the challenges facing International Principles, We provide them with single channel of communication & single point of management . We take all the necessary steps in order to provide our patients with Access to the state of the art Medical technologies and Medical devices of the highest standard whilst still delivering Value for Money. With an ability to be sensitive towards market dynamism, Magal is evolving continuously, offering a better and wider spectrum of products that are innovative, affordable and at the forefront of medical technology to its valued clients. We carry out our business with the highest level of ethics and morality, adopting a strict code of conduct in keeping with those of the medical profession. The Future Magal Healthcare envisages adding more no of healthcare products to its current list that will enable it to provide more comprehensive solutions to meet the ever growing product and process demands of customers. Customer base The great amount of trust and faith reposed by customers in Magal Healthcare's capabilities is evident from its long list of customers, who always turn to Magal Healthcare to fulfill their ever growing requirements. Magal Healthcare Pvt. Ltd. to be identified by the industry as one stop shop for all healthcare related equipment distributor and equipped with sufficient, proper people for sales, service and administration. Visit:http://magal.in

As of 2014, Agilent Technologies, Inc. (U.S.) held the leadership position in the global market. Over the past three years, the company adopted new product launches and strategic acquisitions as its key business strategies to ensure its dominant position in this market. In addition, TE Connectivity Ltd. (Switzerland), Danaher Corporation (U.S.), E.S.I. Environment Sensors Inc. (Canada), Honeywell International, Inc. (U.S.), Lockheed Martin Corporation (U.S.), Ball Aerospace and Technologies Corporation (U.S.), The Raytheon Company (U.S.), Siemens AG (Germany), and Thales Group (France) are some of the other key players in this market.

Based on the technologies, the global Immunoassay Market is segmented into ELISA, rapid tests, western blot tests, enzyme-linked immunospot (ELISPOT) assay, radioimmunoassays (RIA), and PCR. The immunoassay market for ELISA testing is further categorized into first-generation, second-generation, third-generation, and fourth-generation ELISA.

This report studies the global nuclear medicine market over the forecast period 2012-2017. The global radiopharmaceutical market was valued at $3.8 billion in 2012 and is poised to reach $5.5 billion by 2017 at a CAGR of 7.8%.

[201 Slides Report] Browse 133 market tables and 29 figures/charts on Magnetic Resonance Imaging (MRI) Market report categorizes the Global MRI Systems by Technology, Applications, Architecture, Field Strengths & by Geography in Medical Diagnostics with Market Landscape Analysis

[125 Pages Report] Automated External Defibrillator (AED) Market report categorizes Semi-Automated & Fully Automated Defibrillators Global Market by Trends, Technology, End Users & by Geography

Healthcare / Medical Simulation Market report categorizes the global market by Services, by Technology (Haptic, Virtual Reality), End-Users (Academics, Hospitals, Military), by Product (Patient Simulator, Surgical Simulator, Imaging Simulation, Task Trainer) & by Geography